These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30352309)

  • 1. Anti Müllerian Hormone: More than a biomarker of female reproductive function.
    Victoria M; Labrosse J; Krief F; Cédrin-Durnerin I; Comtet M; Grynberg M
    J Gynecol Obstet Hum Reprod; 2019 Jan; 48(1):19-24. PubMed ID: 30352309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physiology and clinical utility of anti-Mullerian hormone in women.
    Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
    Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
    Broer SL; Broekmans FJ; Laven JS; Fauser BC
    Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome.
    Dumont A; Robin G; Dewailly D
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):377-384. PubMed ID: 30299432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does the serum AMH assay allow predicting reliably female fertility?].
    Rolland AL; Dewailly D
    Gynecol Obstet Fertil; 2015 Oct; 43(10):670-5. PubMed ID: 26388252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian hormone as a predictor of reproductive potential.
    Hawkins Bressler L; Steiner A
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):385-390. PubMed ID: 30299431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of AMH in Prediction of Menopause.
    de Kat AC; Broekmans FJM; Lambalk CB
    Front Endocrinol (Lausanne); 2021; 12():733731. PubMed ID: 34594304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of anti-Müllerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome.
    Safier LZ; Grossman LC; Chan CW; Sauer MV; Lobo RA; Douglas NC
    Int J Gynaecol Obstet; 2016 Oct; 135(1):73-6. PubMed ID: 27350232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of serum anti-Müllerian hormone as an ovarian reserve marker: A review of recent studies.
    Iwase A; Osuka S; Goto M; Murase T; Nakamura T; Takikawa S; Kikkawa F
    J Obstet Gynaecol Res; 2018 Jun; 44(6):998-1006. PubMed ID: 29517134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-Müllerian hormone is a clinical useful measure of the ovarian reserve].
    Hyldgaard JM; Ingerslev HJ; Tørring N; Madsen HN; Bor P
    Ugeskr Laeger; 2015 Jan; 177(5):V09140477. PubMed ID: 25650516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone as a qualitative marker - or just quantity?
    Kotlyar A; Seifer DB
    Curr Opin Obstet Gynecol; 2020 Jun; 32(3):219-226. PubMed ID: 32205525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Level of AMH as a predictor of the result of ovarian stimulation].
    Vrublovský P
    Ceska Gynekol; 2016 Jan; 81(1):23-6. PubMed ID: 26982060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of serum AMH levels in gynecology: indications and limits].
    Streuli I; Cantero-Perez P; Miserez-Zaugg C
    Rev Med Suisse; 2013 Oct; 9(403):1954-6, 1958. PubMed ID: 24245018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a place for AMH testing in Canada?
    Green JA; Graves G
    J Obstet Gynaecol Can; 2011 Jun; 33(6):628-632. PubMed ID: 21846454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
    Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
    Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness and indications of AMH assay in women].
    Fouquet A; Catteau-Jonard S; Peigné M; Pigny P; Dewailly D
    Ann Biol Clin (Paris); 2014; 72(6):681-8. PubMed ID: 25486664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMH as the primary marker for fertility.
    Dewailly D; Laven J
    Eur J Endocrinol; 2019 Dec; 181(6):D45-D51. PubMed ID: 31398713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 20. [What's new in 2014 about anti-Müllerian hormone?].
    Seroka-Vanhove A; Sonigo C; Roche C; Grynberg M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Oct; 43(8):559-71. PubMed ID: 25042625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.